Literature DB >> 31412192

Alpelisib for PIK3CA-Mutated Advanced Breast Cancer.

Mehmet S Copur1, Pornchai Jonglertham1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31412192     DOI： 10.1056/NEJMc1907856

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  Analysis of Circulating Tumor DNA to Predict Neoadjuvant Therapy Effectiveness and Breast Cancer Recurrence.

Authors:  Shuai Hao; Wuguo Tian; Jianjie Zhao; Yi Chen; Xiaohua Zhang; Bo Gao; Yujun He; Donglin Luo
Journal:  J Breast Cancer       Date:  2020-07-10       Impact factor: 3.588

2.  Characterization, management, and risk factors of hyperglycemia during PI3K or AKT inhibitor treatment.

Authors:  Dazhi Liu; Michael A Weintraub; Christine Garcia; Marcus D Goncalves; Ann Elizabeth Sisk; Alissa Casas; James J Harding; Stephen Harnicar; Alexander Drilon; Komal Jhaveri; James H Flory
Journal:  Cancer Med       Date:  2022-02-25       Impact factor: 4.711
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.